Literature DB >> 1409574

A model of the platelet factor 4 complex with heparin.

J A Stuckey1, R St Charles, B F Edwards.   

Abstract

A model of heparin bound to bovine platelet factor 4 (BPF4) was completed using a graphically designed heparin molecule and the crystallographic coordinates of the native bovine platelet factor 4 tetramer. The oligosaccharides had a chain length of at least eight disaccharide units with the major repeating disaccharide unit consisting of (1----4)-O-(alpha-L-idopyranosyluronic acid 2-sulfate)-(1----4)-(2-deoxy-2-sulfamino-2-D-glucopyranosyl 6-sulfate). Each disaccharide unit carried a -4.0 charge. The structure of BPF4 was solved to 2.6 A resolution with R = 0.237. Each monomer of BPF4 contains an alpha-helix lying across 3 strands of antiparallel beta-sheet. Each helix has four lysines, which have been implicated in heparin binding. These lysine residues are predominantly on one side of the helix and are solvent accessible. Electrostatic calculations performed on the BPF4 tetramer show a ring of strong, positive charge which runs perpendicularly across the helices. Included in this ring of density is His-38, which has been shown by NMR to have a large pKa shift when heparin binds to BPF4. Our model of heparin bound to PF4 has the anionic polysaccharide perpendicular to the alpha-helices, wrapped about the tetramer along the ring of positive charge, and salt linked to all four lysines on the helix of each monomer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409574     DOI: 10.1002/prot.340140213

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  19 in total

1.  Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.

Authors:  Laurent O Mosnier
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

2.  Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice.

Authors:  Sanjay Srivastava; Srinivas D Sithu; Elena Vladykovskaya; Petra Haberzettl; David J Hoetker; Maqsood A Siddiqui; Daniel J Conklin; Stanley E D'Souza; Aruni Bhatnagar
Journal:  Atherosclerosis       Date:  2011-03-02       Impact factor: 5.162

3.  Platelet Factor 4 Interactions with Short Heparin Oligomers: Implications for Folding and Assembly.

Authors:  Chendi Niu; Yang Yang; Angela Huynh; Ishac Nazy; Igor A Kaltashov
Journal:  Biophys J       Date:  2020-04-21       Impact factor: 4.033

Review 4.  So you think computational approaches to understanding glycosaminoglycan-protein interactions are too dry and too rigid? Think again!

Authors:  Nehru Viji Sankaranarayanan; Balaji Nagarajan; Umesh R Desai
Journal:  Curr Opin Struct Biol       Date:  2018-01-09       Impact factor: 6.809

5.  Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer.

Authors:  Tina Wiesner; Stefanie Bugl; Frank Mayer; Jörg T Hartmann; Hans-Georg Kopp
Journal:  Clin Exp Metastasis       Date:  2010-02-25       Impact factor: 5.150

6.  Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.

Authors:  Jamie S Mader; Daniel Smyth; Jean Marshall; David W Hoskin
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 7.  Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).

Authors:  Zheng Cai; Zhiqiang Zhu; Mark I Greene; Douglas B Cines
Journal:  Autoimmun Rev       Date:  2016-03-09       Impact factor: 9.754

8.  Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.

Authors:  Miriam E Jaax; Krystin Krauel; Thomas Marschall; Sven Brandt; Julia Gansler; Birgitt Fürll; Bettina Appel; Silvia Fischer; Stephan Block; Christiane A Helm; Sabine Müller; Klaus T Preissner; Andreas Greinacher
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

9.  Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes.

Authors:  C J Talpas; L Lee
Journal:  J Protein Chem       Date:  1993-06

10.  Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.

Authors:  K H Mayo; E Ilyina; V Roongta; M Dundas; J Joseph; C K Lai; T Maione; T J Daly
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.